<DOC>
	<DOCNO>NCT01629225</DOCNO>
	<brief_summary>The purpose study investigate association GRK4 polymorphisms essential hypertension southwestern Han Chinese test whether polymorphism associate change blood pressure patient essential hypertension treat angiotensin II Type antagonist candesartan .</brief_summary>
	<brief_title>GRK4 Polymorphisms Blood Pressure Response Candesartan</brief_title>
	<detailed_description>All antihypertensive agent withdrawn start 4-6 week , single-blind , patient receive candesartan 10 mg 20mg daily monotherapy single-blind fashion . The dos double 1 week DBP â‰¥ 90 mmHg .</detailed_description>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>men woman mild moderate essential hypertension southwestern Han Chinese subject unwilling participate subject measurement require , subject medication , affect blood pressure whose DNA fail amplify 8 error Mendelian segregation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>men woman</keyword>
	<keyword>southwestern Han Chinese</keyword>
</DOC>